Exhibit 99.1

                            Certification Pursuant to
                  18 USC, Section 1350, as Adopted Pursuant to
             Sections 302 and 906 of the Sarbanes-Oxley Act of 2002


In connection with the Quarterly Report of ProHealth Medical Technologies,  Inc.
(ProHealth Medical Technologies or Company) on Form 10-QSB for the quarter ended
September  30,  2002  (Report),  as  filed  with  the  Securities  and  Exchange
Commission,  on the date hereof, I, Glenn A. Little, Chief Executive Officer and
Chief  Financial  Officer of the Company,  certify to the best of my  knowledge,
pursuant to 18 USC 1350, as adopted pursuant to ss.302 and promulgated as 18 USC
1350 pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

1.   The Report referenced above has been read and reviewed by the undersigned.

2.   The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934.

3.   The Report  referenced  above does not  contain any untrue  statement  of a
     material fact or omit to state a material fact  necessary in order to makes
     the  statements  made,  in  light of the  circumstances  under  which  such
     statements were made, not misleading.

          I acknowledge that the management of the Company is solely responsible
          for the fair presentation in the financial statements of the financial
          position,  results  of  operations  and cash  flows of the  Company in
          conformity with accounting principles generally accepted in the United
          States of America.

          Based upon my  knowledge,  the  financial  statements,  and other such
          financial  information  included  in the  report,  fairly  present the
          financial  condition and results of  operations  of ProHealth  Medical
          Technologies, Inc. as of and for the period ended September 30, 2002.

          In my opinion, the accompanying interim financial statements, prepared
          in accordance with the instructions for Form 10-QSB, are unaudited and
          contain all material adjustments,  consisting only of normal recurring
          adjustments  necessary  to  present  fairly the  financial  condition,
          results of operations and cash flows of the Company for the respective
          interim  periods  presented.  The current period results of operations
          are not  necessarily  indicative of results which  ultimately  will be
          reported for the full fiscal year ending December 31, 2002.

4.   I acknowledge  that the Company's  Board of Directors  and  Management  are
     responsible  for  establishing  and  maintaining  disclosure  controls  and
     procedures  for ProHealth  Medical  Technologies,  Inc.  These controls and
     systems are designed to ensure that material  information  is made known to
     the Board of Directors and Management of the Company,  particularly  during
     the period in which this periodic report is being  prepared.  The Company's
     Board of Directors and Management have evaluated the  effectiveness  of the
     Company's  disclosure controls and procedures within 90 days of the date of
     this periodic filing.

5.   I acknowledge  that the Company's  Board of Directors  and  Management  are
     solely  responsible for adopting sound accounting  practices,  establishing
     and maintaining a system of internal  accounting control and preventing and
     detecting  fraud. The Company's  system of internal  accounting  control is
     designed to assure,  among other items,  that 1) recorded  transactions are
     valid; 2) valid transactions are recorded; and 3) transactions are recorded
     in the proper  period in a timely  manner to produce  financial  statements
     which present  fairly the financial  condition,  results of operations  and
     cash flows of the Company for the respective periods being presented.



Exhibit 99.1

                            Certification Pursuant to
                  18 USC, Section 1350, as Adopted Pursuant to
             Sections 302 and 906 of the Sarbanes-Oxley Act of 2002


                                   - Page 2 -

     All  significant   weaknesses  in  the  design  or  operation  of  internal
     accounting   controls  which  could  adversely  affect  ProHealth   Medical
     Technologies'  ability to record,  process,  summarize and report financial
     data  have been  identified  by the  Company's  Board of  Directors  and/or
     Management  have  been  reported  to the  Company's  independent  auditors.
     Additionally,   any  fraud,  whether  material  or  not  to  the  financial
     statements of ProHealth Medical  Technologies,  that involves management or
     other  employees  who  have a  significant  role in the  issuer's  internal
     accounting  controls  have also been  reported  to the  Company's  Board of
     Directors and/or Management and to the Company's independent auditors.

6.   I have made the appropriate  disclosures related to any significant changes
     to the Company's system of internal accounting controls or in other factors
     that could  significantly  affect our internal accounting control system or
     the financial reporting derived therefrom.


/s/ Glenn A. Little                                      Dated: October 10, 2002
---------------------------                                     ----------------
Glenn A. Little
Chief Executive Officer and
Chief Financial Officer